ProjectU2 – Universal CAR T cell therapy in autoimmune and malignant disease
Basic data
Acronym:
U2
Title:
Universal CAR T cell therapy in autoimmune and malignant disease
Duration:
01/08/2017 to 01/08/2020
Abstract / short description:
Highly functional transgenic T cells are used for the treatment of autoimmune phenomena as well as for malignant disease while negative feedback mechanisms are abrogated
Keywords:
immunology
Immunologie
Involved staff
Managers
Schlegel, Patrick
Faculty of Medicine
University of Tübingen
University of Tübingen
Faculty of Medicine
University of Tübingen
University of Tübingen
Contact persons
Faculty of Medicine
University of Tübingen
University of Tübingen
Faculty of Medicine
University of Tübingen
University of Tübingen
Local organizational units
Paediatrics Department I and Polyclinic
University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Tübingen, Baden-Württemberg, Germany